Life Sciences: IP/Patent Litigation
California
12 years ranked
Provided by Jones Day
A first-chair trial lawyer and trusted appellate advocate, Ed Reines has extensive experience in competitor vs. competitor disputes involving the life sciences, biotech, and high-technology industries.
Ed has successfully represented clients in high-stakes disputes for decades. His recent achievements before joining Jones Day in 2025 include overturning a $96 million verdict in a patent case involving genetic technologies, winning a $45 million verdict in a Lanham Act false advertising lawsuit regarding diagnostic tests, a $24 million verdict in a case related to prenatal genetic testing methods with a defense verdict on a $105 million contract claim, scoring a judgment of more than $50 million in a case involving microfluidic technologies, and a complete summary judgment in a sprawling multidistrict patent litigation.
The State University of New York, Albany (B.S., 1985); Columbia Law School (J.D., 1988)
Provided by Chambers
Edward Reines is noted for his work representing life sciences companies in contentious IP matters, both at trial and appeal. He regularly appears before both district and federal courts.
Provided by Chambers
Ed is outstanding to work with and really focuses on winning.
Ed is an experienced first chair trial attorney, who develops themes and strategy and knows what is relevant to win a case.
Ed may be the smartest lawyer I have ever met - he is always three steps ahead.
Ed Reines is a terrific attorney. He has a tremendous amount of trial and appellate experience.
Edward Reines has outstanding client management skills.
Ed Reines is a terrific attorney. He has a tremendous amount of trial and appellate experience.
Chambers is the leading data and intelligence partner for the legal sector.